| |
|
興梠 博次 |
熊本大学生命科学研究部呼吸器内科学教授 |
| |
＜研究論文＞
Allergen exposure induces the expression of endothelial adhesion molecules in passively sensitized human bronchus: time course and the role of cytokines. Hirata N, Kohrogi H, Iwagoe H, Goto E, Hamamoto J, Fujii K, Yamaguchi T, Kawano O, Ando M. Am J Respir Cell Mol Biol 1998; 18: 12-20.
|
＜著作＞
「シンプル呼吸器学」興梠博次（編集）共著, 南江堂,2015
|
＜学術的発表＞
Isolation and immortalization of human bronchial intraepithelial T lymphocytes. S. Hirosako, H. Kohrogi, E. Goto, K. Tsumori, S. Hirayama,et al. American Thoracic Society International Conference,2001.
|
|
| |
|
桑名 正隆 |
日本医科大学大学院医学研究科 大学院教授 |
| アレルギー膠原病内科学 |
＜研究論文例＞
Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, and Ikeda Y. Defective vasculogenesis in systemic sclerosis. Lancet. 2004; 364(9434): 603-610.
|
＜研究論文例＞
Gono T, and Kuwana M. Choosing the right biomarkers to predict ILD in myositis. Nat. Rev. Rheumatol. 2016; 12(9): 504-506. doi:10.1038/nrrheum.2016.120
|
＜著作例＞
Kuwana M and Medsger TA, Jr. The clinical aspects of autoantibodies. In “Scleroderma -From Pathogenesis to Comprehensive Management”. Second edition. Edited by Varga J, Denton CP, Wigley FM, Allanore Y, and Kuwana M: Springer, New York, USA. 2017: p207-220.
|
|
| |
|
竹内 勤 |
慶應義塾大学病院 病院長
慶應義塾大学医学部教授
|
| リウマチ・膠原病内科学 |
| Kaneko Y, Atsumi T, Tanaka Y, Inoo M, Kobayashi-Haraoka H, Amano K, Miyata M, Murakawa Y, Yasuoka H, Hirata S, Nagasawa H, Tanaka E, Miyasaka N, Yamanaka H, Yamamoto K, and Takeuchi T. Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study). Ann Rheum Dis (IF=12.811), 75:1917-23, 2016. |
| Tasaki S, Suzuki K, Nishikawa A, Kassai Y, Takiguchi M, Kurisu R, Okuzono Y, Miyazaki T, Takeshita M, Yoshimoto K, Yasuoka H, Yamaoka K, Ikeura K, Tsunoda K, Morita R, Yoshimura A, Toyoshiba H, and Takeuchi T. Multi-omic disease signatures converge to cytotoxic CD8 T-cells in primary Sjogren’s syndrome. Ann Rheum Dis (IF=12.811), online May 18, 2017. |
| Takeuchi T, Thorme JC, Karpouzas G, Sheng S, Xu W, Rao R, Fei K, Hsu B, and Tak P. Sirukumab for rheumatoid arthritis: the phase III, SIRROUND-D study. Ann Rheum Dis, online August 30, 2017. |
|
